The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intrathecal Drug-Global Market Insights and Sales Trends 2025
Synopsis
Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
The global Intrathecal Drug market size is expected to reach US$ 885 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Intrathecal Drug in various end use industries. The expanding demands from the Adult and Child & Teen, are propelling Intrathecal Drug market. Baclofen Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ziconotide Intrathecal Infusion segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intrathecal Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intrathecal Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intrathecal Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intrathecal Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intrathecal Drug covered in this report include Medtronic, Jazz Pharmaceuticals, West Ward Pharmaceutical, Saol Therapeutics, Piramal Critical Care and Fresenius Kabi, etc.
The global Intrathecal Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Global Intrathecal Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intrathecal Drug market, Segment by Type:
Baclofen Injection
Ziconotide Intrathecal Infusion
Morphine Injection
Global Intrathecal Drug market, by Application
Adult
Child & Teen
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intrathecal Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intrathecal Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
The global Intrathecal Drug market size is expected to reach US$ 885 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Intrathecal Drug in various end use industries. The expanding demands from the Adult and Child & Teen, are propelling Intrathecal Drug market. Baclofen Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ziconotide Intrathecal Infusion segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intrathecal Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intrathecal Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intrathecal Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intrathecal Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intrathecal Drug covered in this report include Medtronic, Jazz Pharmaceuticals, West Ward Pharmaceutical, Saol Therapeutics, Piramal Critical Care and Fresenius Kabi, etc.
The global Intrathecal Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Global Intrathecal Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intrathecal Drug market, Segment by Type:
Baclofen Injection
Ziconotide Intrathecal Infusion
Morphine Injection
Global Intrathecal Drug market, by Application
Adult
Child & Teen
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intrathecal Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intrathecal Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Intrathecal Drug Market Overview
1.1 Intrathecal Drug Product Overview
1.2 Intrathecal Drug Market Segment by Type
1.2.1 Baclofen Injection
1.2.2 Ziconotide Intrathecal Infusion
1.2.3 Morphine Injection
1.3 Global Intrathecal Drug Market Size by Type
1.3.1 Global Intrathecal Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Intrathecal Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intrathecal Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intrathecal Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intrathecal Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intrathecal Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intrathecal Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intrathecal Drug Sales Breakdown by Type (2018-2023)
2 Global Intrathecal Drug Market Competition by Company
2.1 Global Top Players by Intrathecal Drug Sales (2018-2023)
2.2 Global Top Players by Intrathecal Drug Revenue (2018-2023)
2.3 Global Top Players by Intrathecal Drug Price (2018-2023)
2.4 Global Top Manufacturers Intrathecal Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intrathecal Drug Market Competitive Situation and Trends
2.5.1 Intrathecal Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intrathecal Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intrathecal Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Intrathecal Drug Market
2.8 Key Manufacturers Intrathecal Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intrathecal Drug Status and Outlook by Region
3.1 Global Intrathecal Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intrathecal Drug Historic Market Size by Region
3.2.1 Global Intrathecal Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Intrathecal Drug Sales in Value by Region (2018-2023)
3.2.3 Global Intrathecal Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intrathecal Drug Forecasted Market Size by Region
3.3.1 Global Intrathecal Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Intrathecal Drug Sales in Value by Region (2024-2029)
3.3.3 Global Intrathecal Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intrathecal Drug by Application
4.1 Intrathecal Drug Market Segment by Application
4.1.1 Adult
4.1.2 Child & Teen
4.2 Global Intrathecal Drug Market Size by Application
4.2.1 Global Intrathecal Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Intrathecal Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intrathecal Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intrathecal Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intrathecal Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intrathecal Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intrathecal Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intrathecal Drug Sales Breakdown by Application (2018-2023)
5 North America Intrathecal Drug by Country
5.1 North America Intrathecal Drug Historic Market Size by Country
5.1.1 North America Intrathecal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intrathecal Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Intrathecal Drug Sales in Value by Country (2018-2023)
5.2 North America Intrathecal Drug Forecasted Market Size by Country
5.2.1 North America Intrathecal Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Intrathecal Drug Sales in Value by Country (2024-2029)
6 Europe Intrathecal Drug by Country
6.1 Europe Intrathecal Drug Historic Market Size by Country
6.1.1 Europe Intrathecal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intrathecal Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Intrathecal Drug Sales in Value by Country (2018-2023)
6.2 Europe Intrathecal Drug Forecasted Market Size by Country
6.2.1 Europe Intrathecal Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Intrathecal Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Intrathecal Drug by Region
7.1 Asia-Pacific Intrathecal Drug Historic Market Size by Region
7.1.1 Asia-Pacific Intrathecal Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intrathecal Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intrathecal Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intrathecal Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Intrathecal Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intrathecal Drug Sales in Value by Region (2024-2029)
8 Latin America Intrathecal Drug by Country
8.1 Latin America Intrathecal Drug Historic Market Size by Country
8.1.1 Latin America Intrathecal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intrathecal Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intrathecal Drug Sales in Value by Country (2018-2023)
8.2 Latin America Intrathecal Drug Forecasted Market Size by Country
8.2.1 Latin America Intrathecal Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intrathecal Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Intrathecal Drug by Country
9.1 Middle East and Africa Intrathecal Drug Historic Market Size by Country
9.1.1 Middle East and Africa Intrathecal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intrathecal Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intrathecal Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intrathecal Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Intrathecal Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intrathecal Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Intrathecal Drug Products Offered
10.1.5 Medtronic Recent Development
10.2 Jazz Pharmaceuticals
10.2.1 Jazz Pharmaceuticals Company Information
10.2.2 Jazz Pharmaceuticals Introduction and Business Overview
10.2.3 Jazz Pharmaceuticals Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Jazz Pharmaceuticals Intrathecal Drug Products Offered
10.2.5 Jazz Pharmaceuticals Recent Development
10.3 West Ward Pharmaceutical
10.3.1 West Ward Pharmaceutical Company Information
10.3.2 West Ward Pharmaceutical Introduction and Business Overview
10.3.3 West Ward Pharmaceutical Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 West Ward Pharmaceutical Intrathecal Drug Products Offered
10.3.5 West Ward Pharmaceutical Recent Development
10.4 Saol Therapeutics
10.4.1 Saol Therapeutics Company Information
10.4.2 Saol Therapeutics Introduction and Business Overview
10.4.3 Saol Therapeutics Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Saol Therapeutics Intrathecal Drug Products Offered
10.4.5 Saol Therapeutics Recent Development
10.5 Piramal Critical Care
10.5.1 Piramal Critical Care Company Information
10.5.2 Piramal Critical Care Introduction and Business Overview
10.5.3 Piramal Critical Care Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Piramal Critical Care Intrathecal Drug Products Offered
10.5.5 Piramal Critical Care Recent Development
10.6 Fresenius Kabi
10.6.1 Fresenius Kabi Company Information
10.6.2 Fresenius Kabi Introduction and Business Overview
10.6.3 Fresenius Kabi Intrathecal Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Fresenius Kabi Intrathecal Drug Products Offered
10.6.5 Fresenius Kabi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intrathecal Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intrathecal Drug Industrial Chain Analysis
11.4 Intrathecal Drug Market Dynamics
11.4.1 Intrathecal Drug Industry Trends
11.4.2 Intrathecal Drug Market Drivers
11.4.3 Intrathecal Drug Market Challenges
11.4.4 Intrathecal Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intrathecal Drug Distributors
12.3 Intrathecal Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
